Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

Author:

Sung Ki‐Chul1ORCID,Sung Jung Hoon2,Cho Eun Joo3,Ahn Jeong Cheon4,Han Seung Hwan5,Kim Weon6,Kim Kye Hun7,Sohn Il Suk8,Shin Jinho9ORCID,Kim Seok Yeon10,Kim Kwang‐il11,Kang Seok Min12,Park Sung‐Ji13,Kim Yong‐Jin14,Shin Joon‐Han15,Park Seong‐Mi16,Park Chang‐Gyu17ORCID

Affiliation:

1. Division of Cardiology Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea

2. Division of Cardiology Bundang CHA Medical Center Sungnam Korea

3. Division of Cardiology Yeouido St. Mary's Hospital Catholic University Seoul Korea

4. Department of Cardiology Korea University Ansan Hospital Ansan Korea

5. Division of Cardiology Gachon University Gil Hospital Incheon Korea

6. Division of Cardiology and Internal Medicine Kyung Hee University Hospital Seoul Korea

7. Department of Cardiovascular Medicine Chonnam National University Medical School/Hospital KwangJu Korea

8. Department of Cardiology College of Medicine Kyung Hee University and Kyung Hee University Hospital at Gangdong Seoul Korea

9. Department of Internal Medicine Hanyang University Seoul Hospital Seoul Korea

10. Division of Cardiology Seoul Medical Center Seoul Korea

11. Department of Internal Medicine Seoul National University College of Medicine and Seoul National University Bundang Hospital Seoul Korea

12. Division of Cardiology Yonsei Cardiovascular Hospital Seoul Korea

13. Division of Cardiology Samsung Medical Center Seoul Korea

14. Division of Cardiology Seoul National University Hospital Seoul Korea

15. Department of Cardiology Ajou University Medical Center Suwon Korea

16. Division of Cardiology Korea University Anam Hospital Seoul Korea

17. Division of Cardiology Korea University Guro Hospital Seoul Korea

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3